Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.

Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60 micrograms/kg of body weight to 22 patients with transitional cell carcinoma before chemotherapy as part of a Phase I/II study. In all patients, a specific dose-dependent increase in the absolute neu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gabrilove, J L, Jakubowski, A, Fain, K, Grous, J, Scher, H, Sternberg, C, Yagoda, A, Clarkson, B, Bonilla, M A, Oettgen, H F
Formato: Artigo
Idioma:Inglês
Publicado em: 1988
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC442704/
https://ncbi.nlm.nih.gov/pubmed/2459163
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados